🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
The vast majority of patients with ALL will die of the disease, and no stan...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-01-01
Trial ID
NCT03318419
Treatments Being Tested
The vast majority of patients with AML will die of the disease, and no stan...
Status
Unknown
Location
Liang Wang
Start Date
2016-01-01
Trial ID
NCT03181815
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2007-12
Trial ID
NCT00602225
Treatments Being Tested
CLAG-M is an active, well tolerated regimen in acute myelogenous leukemia. ...
Status
Unknown
Location
Westchester Medical Center/New York Medical College
Start Date
2012-01
Trial ID
NCT01513603
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
Phase I trial to study the effectiveness of augmerosen plus fludarabine and...
Status
Completed
Location
Arthur G. James Cancer Hospital - Ohio State University
Start Date
1999-10
Trial ID
NCT00004862
Treatments Being Tested